As publicações

A lista de 121 publicações de 2025 (janeiro a outubro) inclui também os novos membros do iii. Queremos mostrar que esses são tão produtivos quanto os membros fundadores e que trabalham com excelência em seus campos de atuação, trazendo mais e mais qualidade ao iii de hoje.

  • Semzezem C, Gomes KFB, Santos AS, Brochet P, Crisostomo LG, Correia MRS, Frade-Barros AF, Brito LA, Passos-Bueno MR, Chevillard C, Cunha-Neto E, da Silva MER. IL17RA and IL21R polymorphisms influence type 1 diabetes predisposition and autoimmune phenotypes. Front Endocrinol (Lausanne). 2025 Sep 4;16:1620509. doi: 10.3389/fendo.2025.1620509.
  • Peixoto HM, Bastos Gottin LL, Brito-Sousa JD, Sampaio V, Daumerie PG, Jambert E, Monteiro W, Lacerda MVG, Devine A. The cost-effectiveness of tafenoquine following screening with STANDARD™ G6PD screening for the treatment of vivax malaria in the Brazilian Public Health System. Lancet Reg Health Am. 2025 Sep 2;51:101216. doi: 10.1016/j.lana.2025.101216.
  • Cerqueira-Silva T, Barral-Netto M, Boaventura VS. Effect of Brazil's national human papillomavirus vaccination programme on the incidence of cervical cancer and cervical intraepithelial neoplasia grade 3 in women aged 20-24 years: a population-based study. Lancet Glob Health. 2025 Oct;13(10):e1715-e1722. doi: 10.1016/S2214-109X(25)00279-7.
  • Fonseca HA, Sampaio Silva G, Monfardini F, Nicolau JC, Rizzo LV, Berwanger O. Influenza vaccination for prevention of death and major cardiovascular events in patients with a history of stroke: a subanalysis of the VIP-ACS trial. Int J Stroke. 2025 Sep 19:17474930251383626. doi: 10.1177/17474930251383626
  • Da Silva KE, Dos Santos PCP, Tsuha DH, Walter KS, Cunha EAT, Colijn C, Cohen T, de Oliveira RD, Bampi JVB, Croda MG, Gonçalves CCM, Demarchi LHF, Croda J, Andrews JR. Comparison of phylogenetic metrics of transmission in symptomatic and asymptomatic tuberculosis. medRxiv [Preprint]. 2025 Sep 2:2025.08.27.25334397. doi: 10.1101/2025.08.27.25334397.
  • Arruda LK, Bernstein JA. Optimizing Diagnosis and Treatment in Chronic Spontaneous and Inducible Urticaria. J Allergy Clin Immunol Pract. 2025 Sep;13(9):2287-2289. doi: 10.1016/j.jaip.2025.07.031.
  • Bardou MLD, Constantino-Silva RN, Alonso MLO, Teixeira AJR, Giavina-Bianchi PF, Mansour E, Pesquero JB, Valle SOR, Grumach AS. Evaluating functional C1INH with multiple laboratory methods across Hereditary Angioedema types. Front Immunol. 2025 Aug 26;16:1654078. doi: 10.3389/fimmu.2025.1654078.
  • Steering Committee Authors; Berges-Gimeno MP, et al. Drug hypersensitivity reactions in children in clinical practice: A WAO Statement. World Allergy Organ J. 2025 Aug 29;18(9):101087. doi: 10.1016/j.waojou.2025.101087.
  • Olagunju AS, Noronha IH, Vasconcelos JRC, Amarante-Mendes GP. Evaluation of in vivo target cell elimination by antigen-specific cytotoxic T lymphocytes. Methods Cell Biol. 2025;197:141-155. doi: 10.1016/bs.mcb.2025.03.025.
  • de Lima FF, Dos Santos JMB, Agondi RC, et al. Minimal clinically important difference in physical activity in people with asthma. ERJ Open Res. 2025 Sep 8;11(5):01285-2024. doi: 10.1183/23120541.01285-2024.
  • Schwambach B, de Lima FF, Pires PP, Agondi RC, Carvalho-Pinto RM, Carvalho CRF. Postural balance and falls in older adults with asthma. J Asthma. 2025 Sep 16:1-9. doi: 10.1080/02770903.2025.2558760.
  • Mieli OM, Valera FCP, Dinarte VRP, et al. One-year efficacy of Dupilumab in CRSwNP patients: A real-world multicenter study in Brazil. Braz J Otorhinolaryngol. 2025 Sep 6;91(6):101704. doi: 10.1016/j.bjorl.2025.101704.
  • Ferriani MPL, Eduardo S Lemos J, Arruda LK, et al. Insights from the first 820 patients from the Brazilian Multicenter Registry of Hereditary Angioedema. J Allergy Clin Immunol Pract. 2025 Sep 3:S2213-2198(25)00827-X. doi: 10.1016/j.jaip.2025.08.026.
  • de Melo TC, Ariga SKK, de Lima TM, Levy D, Bydlowski SP, Soriano FG. Impact of sepsis on bone marrow mesenchymal stem cells. Inflamm Res. 2025 Aug 29;74(1):115. doi: 10.1007/s00011-025-02083-8.
  • Ranzani OT, Lazar Neto F, et al. Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in São Paulo, Brazil. Lancet Infect Dis. 2025 Aug 19:S1473-3099(25)00382-2. doi: 10.1016/S1473-3099(25)00382-2.
  • Erlandson KM, Orkaby AR, et al. Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV. JACC Adv. 2025 Sep;4(9):102077. doi: 10.1016/j.jacadv.2025.102077.
  • Romano A, Valluzzi RL, et al. Updating the classification and routine diagnosis of NSAID hypersensitivity reactions: A WAO Statement. World Allergy Organ J. 2025 Aug 12;18(8):101086. doi: 10.1016/j.waojou.2025.101086.
  • Ribeiro Castro P, Corrêa RO, et al. HIF-1 attenuates high-fiber diet-mediated proliferation and stemness of colonic epithelium. Gut Microbes. 2025 Dec;17(1):2543123. doi: 10.1080/19490976.2025.2543123.
  • Guimarães ES, Gomes MTR, Moraes-Vieira PM, Oliveira SC. Brucella abortus induces DRP1-dependent mitochondrial fission in infected macrophages. J Immunol. 2025 Aug 14:vkaf198. doi: 10.1093/jimmun/vkaf198.
  • Kritski A, Arcêncio R, et al. The Tuberculosis Response and the Role of the BRICS in the Current Global Emergency. Rev Soc Bras Med Trop. 2025 Aug 8;58:e02162025. doi: 10.1590/0037-8682-0216-2025.
  • Marcilio I, Florentino PVT, et al. Leveraging the power of digital health to fight pandemics: The example of ÆSOP. Cien Saude Colet. 2025 Jul;30(7):e19342024. doi: 10.1590/1413-81232025307.19342024.
  • Boscardin SB. Dengue Vaccines. Curr Top Microbiol Immunol. 2025 Aug 13. doi: 10.1007/82_2025_320.
  • Pivetta RS, de Campos NSP, et al. PD-L1 downregulation by carbonic anhydrase IX immunotherapy prompts immune checkpoint blockade in renal cell carcinoma. Eur J Pharm Sci. 2025 Oct 1;213:107190. doi: 10.1016/j.ejps.2025.107190.
  • Rangel ÉB, Tomaz V, et al. Second Edition of the Scientists of Tomorrow/Cientistas do Amanhã Project. Einstein (Sao Paulo). 2025 Aug 1;23:eAE1513. doi: 10.31744/einstein_journal/2025AE1513.
  • Olagunju AS, Loza ML, Rocha MC, Amarante-Mendes GP. Memory T Cells, Recombinant Listeria monocytogenes, and Cancer Vaccines. Front Biosci (Landmark Ed). 2025 Jul 31;30(7):36329. doi: 10.31083/FBL36329.
  • Cerqueira-Silva T, Rodrigues LC, et al. Perinatal outcomes of symptomatic chikungunya, dengue and Zika infection during pregnancy in Brazil. Nat Commun. 2025 Aug 5;16(1):7207. doi: 10.1038/s41467-025-62640-x.
  • da Silva RA, Teixeira RN, et al. Effect of Pharmacological Treatment on Exercise-Induced Bronchoconstriction in Endurance Athletes. Int J Sports Phys Ther. 2025 Aug 1;20(8):1222-1231. doi: 10.26603/001c.141859.
  • Nunes JPDS, Silva MO, et al. Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine. Front Immunol. 2025 Jul 17;16:1610422. doi: 10.3389/fimmu.2025.1610422.
  • Andrade CM, da Silva Gonçalves Í, et al. Oral Treatment With Heat Shock Protein 65-Producing Lactococcus lactis Induces Regulatory T Cells in Leishmania braziliensis Infection. Immunology. 2025 Jul 31. doi: 10.1111/imm.70022.
  • Dos Santos RO, Carvalho NO, et al. IDO1-AhR axis increases T regulatory cells in Plasmodium vivax malaria infection. Front Immunol. 2025 Jul 14;16:1474447. doi: 10.3389/fimmu.2025.1474447.
  • Silva MO, Daher IP, et al. Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants. Virology. 2025 Oct;611:110629. doi: 10.1016/j.virol.2025.110629.
  • Giavina-Bianchi P, Agondi RC, Aun MV, Kalil J. Type 2 Inflammatory Syndrome: Atopic and non-atopic endotypes. World Allergy Organ J. 2025 Jul 1;18(8):101080. doi: 10.1016/j.waojou.2025.101080.
  • Santos-Silva R, Florentino PTV, et al. Primary health care data-based early warning system for dengue outbreaks in Brazil. Lancet Reg Health Am. 2025 Jul 4;48:101165. doi: 10.1016/j.lana.2025.101165.
  • Haider F, Cerqueira-Silva T, et al. Sustained natural immunity following SARS-CoV-2 infection against severe COVID-19 outcomes. BMJ Open. 2025 Jul 16;15(7):e104057. doi: 10.1136/bmjopen-2025-104057.
  • de Jesus Pereira B, Brasil MQA, et al. Chikungunya in a pediatric cohort: Asymptomatic infection, seroconversion, and chronicity rates. PLoS Negl Trop Dis. 2025 Jul 16;19(7):e0013254. doi: 10.1371/journal.pntd.0013254.
  • Santiago-Carvalho I, Francisco R Jr, et al. Sensing of extracellular ATP via P2RX7 drives lung tumor growth through regulatory T cell suppressive function. bioRxiv [Preprint]. 2025 May 8:2025.05.03.652022. doi: 10.1101/2025.05.03.652022.
  • Nunez FA, de Oliveira VL, et al. Electrochemical immunosensor for antibody recognition against SARS-CoV-2 B-cell epitope. J Mater Chem B. 2025 Aug 13;13(32):9925-9936. doi: 10.1039/d5tb00630a.
  • Jalkh AP, Sousa NSO, et al. Cutaneous cryptococcosis resembling keratoacanthoma. Rev Soc Bras Med Trop. 2025 Jul 7;58:e03002024. doi: 10.1590/0037-8682-0300-2024.
  • Barros Verruck J, Moreira Puga MA, et al. Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines. BMJ Public Health. 2025 Jul 5;3(2):e002331. doi: 10.1136/bmjph-2024-002331.
  • Croda J. Commentary: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil. Front Med (Lausanne). 2025 Jun 20;12:1557589. doi: 10.3389/fmed.2025.1557589.
  • Ojeda IC, Thomsen SF, et al. Exploring the impact of chronic urticaria profile as a key predictor of alexithymia. Clin Transl Allergy. 2025 Jul;15(7):e70075. doi: 10.1002/clt2.70075.
  • Yakubu MN, Mwangi VI, et al. Metabolic disruptions in P. vivax malaria: Insights from four antimalarial treatment regimens. Acta Trop. 2025 Aug;268:107722. doi: 10.1016/j.actatropica.2025.107722.
  • Theotonio Dos Santos LF, et al. Education and social determinants shaping HPV vaccine uptake. Hum Vaccin Immunother. 2025 Dec;21(1):2517488. doi: 10.1080/21645515.2025.2517488.
  • Yukari Magawa J, Jacintho LC, et al. Protective role of anti-SARS-CoV-2 antibody responses against vital organ related long COVID symptoms. Sci Rep. 2025 Jul 3;15(1):23705. doi: 10.1038/s41598-025-04152-8.
  • de Leon CDA, Amantea SL, et al. Nutritional status and metabolic alterations in patients with ataxia-telangiectasia. Orphanet J Rare Dis. 2025 Jul 1;20(1):330. doi: 10.1186/s13023-025-03785-2.
  • Rocha GD, Oliveira PRS, et al. Rare genetic variants and severe COVID-19 in previously healthy admixed Latin American adults. Sci Rep. 2025 Jul 2;15(1):23074. doi: 10.1038/s41598-025-08416-1.
  • Pacheco de Campos NS, et al. Carbonic Anhydrase IX and Cyclooxygenase-2 Regulation in Renal Cell Carcinoma and Impact on Anti-CAIX CAR T cells. Curr Top Med Chem. 2025 Jun 27. doi: 10.2174/0115680266364293250613090952.
  • Andrews JR, Charalambous S, et al. The participation of people deprived of liberty in tuberculosis vaccine trials. Lancet Infect Dis. 2025 Jun 27:S1473-3099(25)00305-6. doi: 10.1016/S1473-3099(25)00305-6.
  • Rodrigues Carvalho ML, de Oliveira Andrade C, et al. Targeting PRC2 Enhances the Cytotoxic Capacity of Anti-CD19 CAR T Cells against Hematologic Malignancies. Cancer Res. 2025 Jun 16;85(12):2234-2249. doi: 10.1158/0008-5472.CAN-24-1643.
  • Lopes MM, Castro APM, et al. Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a real-life study. Drugs Context. 2025 Jun 19;14:2025-3-5. doi: 10.7573/dic.2025-3-5.
  • Pardo I, Finamor LPS, et al. Metagenomic Next-Generation Sequencing for the Diagnosis of Infectious Uveitis. Viruses. 2025 May 26;17(6):757. doi: 10.3390/v17060757.
  • Medina A, Sussman J, et al. The concentration of tuberculosis within Paraguay's Indigenous population, 2018-2022. Lancet Reg Health Am. 2025 Jun 10;47:101140. doi: 10.1016/j.lana.2025.101140.
  • Cal K, Leyva A, et al. A nitroalkene derivative of salicylate, SANA, induces creatine-dependent thermogenesis and promotes weight loss. Nat Metab. 2025 Aug;7(8):1550-1569. doi: 10.1038/s42255-025-01311-z.
  • Giglio PN, Levy D, et al. Isolation and Characterization of Articular Cartilage-Derived Cells from Non-Osteoarthritic Patients. Cells. 2025 Jun 3;14(11):830. doi: 10.3390/cells14110830.
  • da Silva Peres Bezerra W, et al. The role of tuberculosis symptoms in transmission risk to cell contacts in prisons. medRxiv [Preprint]. 2025 May 27:2025.05.27.25328413. doi: 10.1101/2025.05.27.25328413.
  • Fichtenbaum CJ, Malvestutto CD, et al. Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial. Lancet HIV. 2025 Jul;12(7):e496-e505. doi: 10.1016/S2352-3018(25)00043-8.
  • de Castro ME, de Siqueira GF, et al. Spatial immune profiling reveals distinct microenvironments in medullary thyroid carcinoma. Front Immunol. 2025 May 21;16:1579205. doi: 10.3389/fimmu.2025.1579205.
  • Souza-Silva TG, Neves EGA, et al. Self and parasite-derived peptides activate CD4+ T cells from Chagas cardiomyopathy patients. Front Immunol. 2025 May 5;16:1527115. doi: 10.3389/fimmu.2025.1527115.
  • Alkwai HM, Almaghlouth IA, Mendonça LO, et al. International multidisciplinary consensus on monogenic inflammatory immune dysregulation disorders. Pediatr Rheumatol Online J. 2025 May 14;23(1):51. doi: 10.1186/s12969-025-01109-z.
  • de Barros Cardoso CR, Cerqueira-Silva T, et al. Dengue Dilemma: Navigating Cross-Reactivity and Immune Challenges. Curr Top Microbiol Immunol. 2025 May 14. doi: 10.1007/82_2025_294.
  • França RKAO, Barros PHA, et al. Naive and Memory B Cell BCR Repertoires in Individuals Immunized with an Inactivated SARS-CoV-2 Vaccine. Vaccines (Basel). 2025 Apr 8;13(4):393. doi: 10.3390/vaccines13040393.
  • Souza MR, Moysés-Oliveira M, et al. Genetic overlap and immunological pathways in asthma-obstructive sleep apnea coexistence. Sleep Breath. 2025 May 7;29(2):178. doi: 10.1007/s11325-025-03341-z.
  • Mabene Y, Bampi J, et al. Tuberculosis treatment outcomes after transfer or release from incarceration. medRxiv [Preprint]. 2025 Apr 20:2025.04.19.25325982. doi: 10.1101/2025.04.19.25325982.
  • da Silva GS, Fontenelle FA, et al. Impact of CYP2D6, MAOA, and UGT2B7 genetic variants on recurrence of Plasmodium Vivax in the Brazilian Amazon. Sci Rep. 2025 May 2;15(1):15330. doi: 10.1038/s41598-025-94679-7.
  • da Cruz MGS, Dos Santos RO, et al. Impact of dengue virus infection on the cytoadherence of Plasmodium vivax-infected erythrocytes. Mem Inst Oswaldo Cruz. 2025 Apr 25;120:e240185. doi: 10.1590/0074-02760240185.
  • Salindri AD, Bampi JVB, et al. Evaluation of an ultra-portable X-ray system for tuberculosis active case finding in prisons. Res Sq [Preprint]. 2025 Apr 7:rs.3.rs-5578367. doi: 10.21203/rs.3.rs-5578367/v1.
  • Ishak CA, Marhon SA, et al. Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion. Cancer Discov. 2025 Apr 2;15(4):793-817. doi: 10.1158/2159-8290.CD-24-0094.
  • Frade AF, Guérin H, Nunes JPS, et al. Cardiac and Digestive Forms of Chagas Disease: An Update on Pathogenesis, Genetics, and Therapeutic Targets. Mediators Inflamm. 2025 Apr 21;2025:8862004. doi: 10.1155/mi/8862004.
  • Adami FL, de Castro MV, et al. Corrigendum: Anti-RBD IgG antibodies from endemic coronaviruses do not protect against SARS-CoV-2 infection. Front Immunol. 2025 Apr 11;16:1598312. doi: 10.3389/fimmu.2025.1598312.
  • Magerl M, Riedl MA, Arruda LK, et al. Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitor. J Allergy Clin Immunol Glob. 2025 Feb 27;4(3):100446. doi: 10.1016/j.jacig.2025.100446.
  • Munhoz DD, Fonseca DLM, et al. Integrative immunology identified interferome signatures in uveitis and systemic disease-associated uveitis. Front Immunol. 2025 Apr 9;16:1509805. doi: 10.3389/fimmu.2025.1509805.
  • Davanzo GG, Castelucci BG, et al. Obesity-Induced Metabolic Priming Exacerbates SARS-CoV-2 Inflammation. Immunology. 2025 Jul;175(3):323-338. doi: 10.1111/imm.13934.
  • Barreto AS, de Franca MNF, et al. Design and development of highly conserved, HLA-promiscuous T cell multiepitope vaccines against human visceral leishmaniasis. Front Immunol. 2025 Mar 31;16:1540537. doi: 10.3389/fimmu.2025.1540537.
  • Murillo-Casas AD, Zwiener R, Giavina-Bianchi P, et al. Latin American guidelines for the diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis. World Allergy Organ J. 2025 Mar 26;18(4):101046. doi: 10.1016/j.waojou.2025.101046.
  • Joseph S, Silbiger VN, et al. Diagnostic and prognostic significance of miRNA-15a-5p, 16-5p, and 92a-3p in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2025 Apr 11:S1547-5271(25)02321-5. doi: 10.1016/j.hrthm.2025.04.014.
  • Levy D, Calllera AF, et al. TNF-Alpha Inhibitor Prevents Cigarette Smoke Extract-Induced Cell Death in Osteoarthritis-Derived Chondrocytes. Cells. 2025 Mar 25;14(7):489. doi: 10.3390/cells14070489.
  • Daher IP, Almeida BDS, et al. Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil. Clin Immunol. 2025 Jul;276:110492. doi: 10.1016/j.clim.2025.110492.
  • Carrara GMP, Souza-Silva GA, et al. Macrophage Protein Disulfide Isomerase Increases Infection by Leishmania amazonensis. Cell Biol Int. 2025 Jul;49(7):785-797. doi: 10.1002/cbin.70020.
  • Barreto-Duarte B, Villalva-Serra K, et al. Directly observed treatment for tuberculosis care and social support. Lancet Reg Health Am. 2025 Feb 13;43:101015. doi: 10.1016/j.lana.2025.101015.
  • Moreira IMB, Sousa NSO, et al. Fluconazole Resistance and Heteroresistance in Cryptococcus spp. Rev Soc Bras Med Trop. 2025 Mar 24;58:e002002025. doi: 10.1590/0037-8682-0328-2024.
  • Bernardi V, Sacchetto L, et al. Yellow Fever Virus in Mosquitoes from Rainforest Bordering Manaus, Brazil, 2022. Emerg Infect Dis. 2025 Apr;31(4):851-854. doi: 10.3201/eid3104.240108.
  • Ferreira CS, Da Silva AT, et al. Immune and vascular modulation by HERVs: the role of CXCR1 and IL18RAP in dengue severity progression. Front Immunol. 2025 Mar 7;16:1557588. doi: 10.3389/fimmu.2025.1557588.
  • Schaan AP, Costa L, et al. Editorial Expression of Concern: mtDNA structure: the women who formed the Brazilian northeast. BMC Ecol Evol. 2025 Mar 21;25(1):26. doi: 10.1186/s12862-025-02366-y.
  • Rouadi PW, Idriss SA, et al. WAO-ARIA consensus on chronic cough: Executive summary. World Allergy Organ J. 2025 Feb 24;18(3):101034. doi: 10.1016/j.waojou.2025.101034.
  • Moreira Puga MA, Dias de Oliveira R, et al. Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines in Brazil. Lancet Reg Health Am. 2025 Feb 22;44:101031. doi: 10.1016/j.lana.2025.101031.
  • de Farias IS, Ribeiro G, et al. Caspase-1/11 controls Zika virus replication in astrocytes by inhibiting glycolytic metabolism. FEBS J. 2025 Jun;292(12):3113-3128. doi: 10.1111/febs.70061.
  • Lacerda MVG, Bassat Q. Mapping the malaria burden in the context of a global pandemic. Lancet. 2025 Mar 22;405(10483):952-953. doi: 10.1016/S0140-6736(25)00418-0.
  • Bonyek-Silva Í, Bastos R, et al. High glucose heightens vulnerability to Leishmania braziliensis infection in human macrophages. Emerg Microbes Infect. 2025 Dec;14(1):2475824. doi: 10.1080/22221751.2025.2475824.
  • de Melo Iani FC, Pereira FM, et al. Travel-associated international spread of Oropouche virus beyond the Amazon. J Travel Med. 2025 Mar 30;32(3):taaf018. doi: 10.1093/jtm/taaf018.
  • Pereira DB, Lacerda MVG, et al. An observational pilot study of an active surveillance tool to enhance pharmacovigilance in Brazil. Malar J. 2025 Mar 3;24(1):71. doi: 10.1186/s12936-025-05295-9.
  • Ghezzi B, Valencia C, et al. A Methodological Approach to Measuring the Impact of TAK-003 for the Prevention of Dengue in Dourados, Brazil. Vaccines (Basel). 2025 Jan 25;13(2):121. doi: 10.3390/vaccines13020121.
  • Reichert CO, Levy D, et al. PON-1 and PON-2 Polymorphisms and PON-1 Paraoxonase Activity in People Living with HIV-1. Antioxidants (Basel). 2025 Feb 12;14(2):209. doi: 10.3390/antiox14020209.
  • Ramundo MS, da Fonseca GC, et al. Transcriptomic insights into early mechanisms underlying post-chikungunya chronic inflammatory joint disease. Sci Rep. 2025 Feb 25;15(1):6745. doi: 10.1038/s41598-025-86761-x.
  • de Rezende DF, Garcia KKS, et al. The 1985 Plasmodium vivax malaria elimination campaign in Santa Catarina, Brazil. Malar J. 2025 Feb 21;24(1):57. doi: 10.1186/s12936-025-05301-0.
  • Florentino PTV, Bertoldo Junior J, et al. Impact of Primary Health Care Data Quality on Infectious Disease Surveillance in Brazil. JMIR Public Health Surveill. 2025 Feb 21;11:e67050. doi: 10.2196/67050.
  • Giavina-Bianchi P, Giavina-Bianchi M, Kalil J. Urticaria unveiled in hereditary angioedema with carboxypeptidase N mutation. J Allergy Clin Immunol Glob. 2025 Jan 10;4(2):100405. doi: 10.1016/j.jacig.2025.100405.
  • Giavina-Bianchi B, Giavina-Bianchi P. Rapid food desensitization associated with omalizumab before oral immunotherapy. World Allergy Organ J. 2025 Jan 28;18(2):101032. doi: 10.1016/j.waojou.2025.101032.
  • Macedo PRC, Moraes P, Arruda LK, et al. Efficacy and safety of sublingual immunotherapy using D. pteronyssinus and B. tropicalis extracts in patients with allergic rhinitis. World Allergy Organ J. 2025 Jan 28;18(2):101020. doi: 10.1016/j.waojou.2024.101020.
  • Gasparoto ALDB, Graeff SV, et al. Mapping the viral battlefield: SARS-CoV-2 infection dynamics among healthcare workers in Brazil. Hum Resour Health. 2025 Feb 11;23(1):8. doi: 10.1186/s12960-024-00968-z.
  • Chaves YO, Gama WM, et al. Association between cytokine and increased risk of death in ART-naïve and ART-non-adherence patients hospitalized with advanced HIV disease. BMC Infect Dis. 2025 Feb 9;25(1):197. doi: 10.1186/s12879-024-10260-z.
  • Noble CCA, McDonald E, et al. Characterising the SARS-CoV-2 nucleocapsid (N) protein antibody response. J Infect. 2025 Mar;90(3):106436. doi: 10.1016/j.jinf.2025.106436.
  • Ensina LF, Brandão L, Arruda LK, et al. IgE as a predictor to omalizumab response in patients with chronic spontaneous urticaria. Front Allergy. 2025 Jan 23;5:1451296. doi: 10.3389/falgy.2024.1451296.
  • de Morais Gomes V, Santos DM, et al. P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response. J Proteomics. 2025 May 15;315:105397. doi: 10.1016/j.jprot.2025.105397.
  • Batestin D, Busatto C, et al. Sputum pooling for rapid and cost-effective active case-finding for TB in prisons. Int J Tuberc Lung Dis. 2025 Feb 1;29(2):88-89. doi: 10.5588/ijtld.24.0358.
  • Messina NL, Germano S, et al. Effect of Bacille Calmette-Guérin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccination. Clin Transl Immunology. 2025 Jan 25;14(1):e70023. doi: 10.1002/cti2.70023.
  • Romão CM, de Lara Janz F, et al. Expression of ABCB1, ABCC1, and LRP in Mesenchymal Stem Cells from Human Amniotic Fluid and Bone Marrow. Int J Mol Sci. 2025 Jan 9;26(2):510. doi: 10.3390/ijms26020510.
  • Perez-Riverol A, Hideki Izuka Moraes G, et al. An Allergomic Study Reveals Two Novel Venom Allergens from the Social Wasp Apoica pallens. Clin Exp Allergy. 2025 Mar;55(3):250-252. doi: 10.1111/cea.14630.
  • Miyaji KT, Ibrahim KY, et al. Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac) and heterologous additional doses of mRNA BNT162b2 in immunocompromised and immunocompetent individuals. Rev Inst Med Trop Sao Paulo. 2025 Jan 20;67:e2. doi: 10.1590/S1678-9946202567002.
  • de Abreu LM, Medina TDS, et al. Four decades of treatment for actinic cheilitis. J Stomatol Oral Maxillofac Surg. 2025 Jun;126(3S):102227. doi: 10.1016/j.jormas.2025.102227.
  • Cabrera-Alarcon JL, Cruz R, et al. Shaping current European mitochondrial haplogroup frequency in response to infection: the case of SARS-CoV-2 severity. Commun Biol. 2025 Jan 9;8(1):33. doi: 10.1038/s42003-024-07314-y.
  • Freitas RCC, Bortolin RH, et al. Integrative analysis of miRNAs and proteins in plasma extracellular vesicles of patients with familial hypercholesterolemia. Clin Chim Acta. 2025 Feb 15;568:120123. doi: 10.1016/j.cca.2025.120123.
  • de Oliveira EC, Tibúrcio R, et al. Pharmacological inhibition of key metabolic pathways attenuates Leishmania spp infection in macrophages. PLoS Negl Trop Dis. 2025 Jan 7;19(1):e0012763. doi: 10.1371/journal.pntd.0012763.
  • Vieceli T, Croda J, et al. The burden, clinical features and outcomes of SARS-CoV-2, Influenza and co-infections in Brazil. Public Health. 2025 Jan;238:101-107. doi: 10.1016/j.puhe.2024.10.016.
  • da Silva Pereira JA, de Souza GP, et al. LXR regulation of adipose tissue inflammation during obesity. Obesity (Silver Spring). 2025 Jan;33(1):78-90. doi: 10.1002/oby.24158.
  • Yamamoto LR, Vianna EDSO, et al. Worse lung function, more allergic sensitization but less blood eosinophilia in elderly patients with long-standing versus late-onset asthma. J Asthma. 2025 May;62(5):751-760. doi: 10.1080/02770903.2024.2438099.
  • Walter KS, Cohen T, et al. Signatures of transmission in within-host Mycobacterium tuberculosis complex variation. Lancet Microbe. 2025 Jan;6(1):100936. doi: 10.1016/j.lanmic.2024.06.003.
  • de Oliveira LA, de Morais IRB, et al. Assessment of the BNT162B2 COVID-19 vaccine immune response in Brazilian indigenous adolescents. Vaccine. 2025 Jan 1;43(Pt 1):126494. doi: 10.1016/j.vaccine.2024.126494.
  • De Lima Gualque MW, Vaso CO, et al. Peptides from Galleria mellonella against Cryptococcus spp. Future Microbiol. 2025 Jan;20(1):11-21. doi: 10.1080/17460913.2024.2421632.
  • Silva JM, França RKAO, et al. Rescuing pathogen-specific memory B-cell from PBMC of prior Zika virus-infected individuals. Immunol Lett. 2025 Feb;271:106944. doi: 10.1016/j.imlet.2024.106944.
  • Martinez EG, Alencar RM, et al. Relative efficacy of anti-Plasmodium vivax malaria combination drugs in preventing transmission to two major Anopheles mosquitoes. Int J Infect Dis. 2025 Jan;150:107297. doi: 10.1016/j.ijid.2024.107297.
  • Buerger V, Hadl S, et al. Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil. Lancet Infect Dis. 2025 Jan;25(1):114-125. doi: 10.1016/S1473-3099(24)00458-4.
  • de Araujo Fernandes AG, et al. [99mTc]Technetium and Rhenium Dithiocarbazate Complexes. Pharmaceutics. 2025 Jan 13;17(1):100. doi: 10.3390/pharmaceutics17010100.
  • Carrasco S, Liphaus BL, et al. Early neutrophil activation and NETs release in the pristane-induced lupus mice model. PLoS One. 2025 Jan 3;20(1):e0306943. doi: 10.1371/journal.pone.0306943.